Julian Robertson Homology Medicines, Inc. Transaction History

Tiger Management L.L.C.

  • $22.8 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$19.76 - $29.57 $469,102 - $701,991
-23,740 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$18.39 - $26.3 $436,578 - $624,362
23,740 New
23,740 $531,000

Others Institutions Holding FIXX

# of Institutions
3
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track Julian Robertson's Portfolio

Track Julian Robertson Portfolio

Follow Julian Robertson (Tiger Management L.L.C.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiger Management L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Tiger Management L.L.C. and Julian Robertson with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email